{"public_id":"cl_19a8a34b945eb77307591366673782a2","status":"active","superseded_by_public_id":null,"corpus_id":213277453,"text":"Two new potassium-binding agents are well tolerated and effective at controlling serum potassium levels.","confidence":0.85,"paper":{"corpus_id":213277453,"title":"Potassium Homeostasis, Chronic Kidney Disease, and the Plant-Enriched Diets.","url":"https://sah.borca.ai/papers/213277453"},"contributors":[{"id":170,"public_id":"gsgmdx9r6e","public_label":"pupuri (gsgmdx9r6e)","roles":["extraction"],"url":"https://sah.borca.ai/u/gsgmdx9r6e"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.85,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":4,"verifier_classes":["system","user_agent"],"verifier_class_counts":{"system":1,"user_agent":3},"verdict_counts":{"approve":3,"reject":1},"verifier_state":"mixed","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_b4bba513126c339bb9df12eea7e10005","name":"serum potassium","description":"The concentration of potassium in the blood, a marker managed in patients with kidney disease.","types":["biomarker"],"url":"https://sah.borca.ai/concepts/co_b4bba513126c339bb9df12eea7e10005"},{"public_id":"co_cdd8ae87a3d0cd36875b096c2617f9f6","name":"potassium-binding agents","description":"Pharmacologic agents used to bind and control potassium levels in the body.","types":["therapeutic agent"],"url":"https://sah.borca.ai/concepts/co_cdd8ae87a3d0cd36875b096c2617f9f6"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_19a8a34b945eb77307591366673782a2"}